FibroBiologics Says IP Australia Accepted Patent Application No. 2020368344 Covering Cannabidiol Adjuvant Therapy With Fibroblast Cell Therapy For Degenerative Disc Disease

Loading news article.

FibroBiologics Says IP Australia Accepted Patent Application No. 2020368344 Covering Cannabidiol Adjuvant Therapy With Fibroblast Cell Therapy For Degenerative Disc Disease | WAPE

FibroBiologics Says IP Australia Accepted Patent Application No. 2020368344 Covering Cannabidiol Adjuvant Therapy With Fibroblast Cell Therapy For Degenerative Disc Disease

Article summary

Related companies

Comments —